Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women
Clinical trial NCT03293108 · UNKNOWN
Trial details
- NCT number
- NCT03293108
- Sponsor
- AryoGen Pharmed Co.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-29
- Primary completion
- 2020-09-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.